HIL Applied Medical
HIL Co-Founder and CTO, Prof. Arie Zigler, announced as a finalist for Berthold Leibinger Innovationspreis 2018 Prof. Arie Zigler, HIL’s Co-Founder and CTO, was announced as a finalist for the Berthold Leibinger Innovationspreis of 2018. Professor Zigler was chosen as …
Continue reading »HIL Featured in The Marker Magazine In its special issue for the 2018 MIXiii Biomed Conference and Exhibition, The Marker Magazine tells the story of HIL and its unique Proton Therapy solution. HIL’s CEO Mr. Sagi Brink-Danan shared our vision and his own …
Continue reading »HIL selected to present at the 19th annual Bio€quity Europe conference The conference will take place on May 14-16 in Ghent, Belgium, at the Convention Center “Het Pand” – Onderbergen 1. Join HIL’s CEO, Mr. Sagi Brink-Danan, for a Next Wave …
Continue reading »HIL makes the shortlist of the Future Planet Awards 2018 HIL was shortlisted for the second annual Future Planet Awards, a prize given to startups that are going to change the world for the better. Future Planet Awards are given by …
Continue reading »HIL awarded two new US patents. These two latest additions – granted to HIL during the past two months – bring HIL’s patent portfolio to over three-dozen granted and pending patents worldwide, out of which over 20 have already been …
Continue reading »HIL scientists publish a paper in HPLSE Journal Omer Shavit, Yair Ferber, Evgeny Papeer, Arie Zigler – all R&D Physicists at HIL, – et. al. recently published a paper titled “Femtosecond laser-induced damage threshold in snow micro-structured targets”. The research …
Continue reading »HIL at OurCrowd’s Global Investor Summit, 2018 OurCrowd’s annual Global Investor Summit in Jerusalem drew a huge crowd of over 10,000 people registered to attend from all around the world. As part of the exciting event, participants were able to …
Continue reading »Mr. Lior Buchman (CPA) joins HIL’s Board of Directors Mr. Buchman has over 20 years of experience in senior corporate financing, mergers & acquisitions, investor relations, operational and business development. Currently the CFO of Integra Holdings Ltd, he has served as …
Continue reading »HIL is awarded a European Union R&D grant under Horizon 2020 Horizon 2020 is the EU’s framework programme for research and innovation. According to the European Commission, it is the biggest EU Research and Innovation programme ever, with nearly €80 billion …
Continue reading »HIL named one of 10 Coolest Biotech Companies in Jerusalem ISRAL21c, together with JLM-BioCity today shared their thoughts on the Coolest Biotech Companies in Jerusalem. The coolest of the cool is #2, of course (at least in our unbiased opinion…). …
Continue reading »